4//SEC Filing
Stergiou Angelos M. 4
Accession 0001104659-25-003501
CIK 0001390478other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 5:34 PM ET
Size
9.9 KB
Accession
0001104659-25-003501
Insider Transaction Report
Form 4
Stergiou Angelos M.
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-10+385,750→ 385,750 totalExercise: $0.95Exp: 2035-01-10→ Common Stock (385,750 underlying) - Award
Common Stock
2025-01-10+257,000→ 615,132 total - Award
Common Stock
2025-01-10+243,900→ 859,032 total
Footnotes (3)
- [F1]The Reporting Person received an award of 257,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date.
- [F2]The Reporting Person received an award of 243,900 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date.
- [F3]One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001724253
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 5:34 PM ET
- Size
- 9.9 KB